Eat Beyond Portfolio Company SingCell to License Technology from National University of Singapore
(firmenpresse) - Vancouver, B.C. & Singapore - April 6, 2021 - Eat Beyond Global Holdings Inc. (CSE: EATS) (OTCPK: EATBF) (FSE: 988) (Eat Beyond or the Company), an investment issuer focused on the global plant-based and alternative food sector, is announcing that its portfolio company SingCell Tx Pte Ltd. (SingCell) has entered into a technology development agreement with the National University of Singapore to evaluate and license its plant-based edible microcarriers technology.
The initial performance of these microcarriers in terms of cell attachment and proliferation is very promising and could solve the cost and scalability issues in the cultured meat industry, said Karolis Rosickas, CEO of SingCell. This technology is very complementary to SingCells existing 3D cell culture technology, and soon we will be able to offer a more comprehensive bioprocessing scale-up solution to our clients.
SingCell operates as a contract development and manufacturing organization (CDMO), offering its proprietary platform to third-party alternative meat companies, which provides scalable processes for cultured meat manufacturing. SingCell has a rapidly growing pipeline of potential projects.
SingCell is focused on improving the feasibility of the cultured meat industry by focusing purely on the cost and scalability of the technology, said Eat Beyond CEO Patrick Morris. The company is also located in Singapore, which is truly the epicenter of this industry and was the first jurisdiction globally to approve cell based meat for consumption.
The Singapore government has placed a major focus on innovation that will drive food security and make the nation less dependent on foreign suppliers. SingCell is well positioned to leverage these programs to develop its technology and manufacturing infrastructure in Singapore.
Learn more about SingCell online at https://www.singcell.com/
About Eat Beyond Global Holdings
Eat Beyond Global Holdings Inc. (Eat Beyond) (CSE: EATS) (OTCPK: EATBF) (FSE: 988) is an investment issuer that makes it easy to invest in the future of food. Eat Beyond identifies and makes equity investments in global companies that are developing and commercializing innovative food tech as well as plant-based and alternative food products. Led by a team of food industry experts, Eat Beyond is the first issuer of its kind in Canada, providing retail investors with the unique opportunity to participate in the growth of a broad cross-section of opportunities in the alternative food sector, and access companies that are leading the charge toward a smarter, more secure food supply. Learn more: https://eatbeyondglobal.com/
Find Eat Beyond on Social Media on LinkedIn, Instagram, Twitter and Facebook
For media inquiries, please contact: Brittany(at)Exvera.com
For investment inquiries, please contact: Info(at)Eatbeyondglobal.com
For further information, please contact Patrick Morris at Info(at)Eatbeyondglobal.com or (236) 521-6499
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
" alt="Sernova Announces Presentation at the American Diabetes Association 81st Scientific Sessions">
" alt="Physician-Led Webinar Sponsored by Perimeter Medical Imaging AI Highlights Advancements in Intraoperative Specimen Imaging ">
Datum: 06.04.2021 - 09:03 Uhr
Sprache: Deutsch
News-ID 1566308
Anzahl Zeichen: 3089
contact information:
Contact person:
Town:
Wien
Phone:
Kategorie:
Business News
Typ of Press Release:
type of sending:
Date of sending:
Anmerkungen:
Diese Pressemitteilung wurde bisher 728 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Eat Beyond Portfolio Company SingCell to License Technology from National University of Singapore
"
steht unter der journalistisch-redaktionellen Verantwortung von
Eat Beyond Global Holdings Inc. (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
